Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of BRAF/MEK inhibitor on BRAF V600E-mutated pilocytic astrocytoma.

Pediatrics international : official journal of the Japan Pediatric Society - 1 Jan 2000

Hamada Ryo, Akane Yusuke, Akiyama Yukinori, Takada Kohichi, Yamamoto Masaki

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms
Share to Mitogen-Activated Protein Kinase Kinases
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 37804006
DOI: 10.1111/ped.15653

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of BRAF/MEK inhibitor on BRAF V600E-mutated pilocytic astrocytoma.PMID 37804006Read ↗

Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma.Semantic proximity Read ↗

The involvement of the MAPK pathway in pilocytic astrocytomas.Semantic proximity Read ↗

MEK Inhibition in a Pilocytic Astrocytoma With a Rare KRAS Q61R Mutation in a Young Adult Patient: A Case Report.Semantic proximity Read ↗

Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm.Semantic proximity Read ↗

Adult pilocytic astrocytoma in the molecular era: a comprehensive reviewSemantic proximity Read ↗

The morphologic and molecular characteristics of pilocytic astrocytomas and the role of MAPK pathway: what does not kill you makes you stronger.Semantic proximity Read ↗

Dabrafenib for Pilocytic Astrocytoma With BRAF V599ins.Semantic proximity Read ↗

Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1N546K Mutation.Semantic proximity Read ↗

The role of BRAF-targeted therapy in astrocytomas: a review.Semantic proximity Read ↗

MAPK pathway activation in pilocytic astrocytomaSemantic proximity Read ↗

Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas.Semantic proximity Read ↗

V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.